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Abstract
Background:  There are increasing numbers of randomised trials and systematic reviews
examining the efficacy of interventions designed to bring about a change in clinical practice. The
findings of this research are being used to guide strategies to increase the uptake of evidence into
clinical practice. Knowledge of the outcomes measured by these trials is vital not only for the
interpretation and application of the work done to date, but also to inform future research in this
expanding area of endeavour and to assist in collation of results in systematic reviews and meta-
analyses.
Methods: The objective of this review was to identify methods used to measure change in the
clinical practices of health professionals following an intervention aimed at increasing the uptake of
evidence into practice. All published trials included in a recent, comprehensive Health Technology
Assessment of interventions to implement clinical practice guidelines and change clinical practice
(n = 228) formed the sample for this study. Using a standardised data extraction form, one reviewer
(SH), extracted the relevant information from the methods and/or results sections of the trials.
Results: Measures of a change of health practitioner behaviour were the most common, with
88.8% of trials using these as outcome measures. Measures that assessed change at a patient level,
either actual measures of change or surrogate measures of change, were used in 28.8% and 36.7%
of studies (respectively). Health practitioners' knowledge and attitudes were assessed in 22.8% of
the studies and changes at an organisational level were assessed in 17.6%.
Conclusion: Most trials of interventions aimed at changing clinical practice measured the effect of
the intervention at the level of the practitioner, i.e. did the practitioner change what they do, or
has their knowledge of and/or attitude toward that practice changed? Less than one-third of the
trials measured, whether or not any change in practice, resulted in a change in the ultimate end-
point of patient health status.
Background
The healthcare professions are increasingly considering
available evidence when determining best practice. Clini-
cal practice guidelines based on the most recent and relia-
ble evidence are designed to keep practitioners up-to-date
with research and assist them in the process of imple-
menting evidence into practice [1]. However, unless clini-
cians adhere to the recommendations of practice
guidelines they will have little or no impact on actual clin-
ical practice.
Published: 06 December 2006
Implementation Science 2006, 1:29 doi:10.1186/1748-5908-1-29
Received: 23 April 2006
Accepted: 06 December 2006
This article is available from: http://www.implementationscience.com/content/1/1/29
© 2006 Hakkennes and Green; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Implementation Science 2006, 1:29 http://www.implementationscience.com/content/1/1/29
Page 2 of 9
(page number not for citation purposes)
Each year a vast number of studies are published and aim
to assess the impact of various strategies for effectively dis-
seminating and implementing clinical practice guidelines.
Numerous systematic reviews have been written that eval-
uate the effectiveness of these different strategies.
Recently, in the most comprehensive review to date,
Grimshaw et al. systematically reviewed 235 studies eval-
uating the effectiveness and cost of various guideline
development, dissemination, and implementation strate-
gies [2]. The majority of the studies included in this review
used measures of process rather than actual patient out-
comes, even though only three of the guidelines were
overtly evidence-based. Although there was an improve-
ment in process of care for the majority of comparisons
reporting dichotomous data (86.6%), the authors found
considerable variation in results both within and between
included studies. The authors concluded that there is
insufficient evidence to determine which guideline dis-
semination and implementation strategies are likely to be
effective under different circumstances, and highlighted
the need for further research.
The Cochrane Effective Practice and Organisation of Care
group (EPOC) performs systematic reviews of interven-
tions designed to improve professional practice and the
delivery of health services [3]. For example, the review by
O'Brien et al concluded that interactive workshops could
result in moderately large changes in professional prac-
tice, while didactic lectures alone were unlikely to effect
change [4]. Together, these studies and reviews are guid-
ing the strategies that health professionals and policy
makers use to facilitate the uptake of evidence into clinical
practice.
Knowledge of the outcome measures employed by studies
investigating the effectiveness of strategies to change prac-
tice is vital, not only for the interpretation and application
of the work done to date, but also to inform future
research in this expanding area of endeavour. Appropriate
choice of outcome measure is important in ensuring both
the internal and external validity of studies. That is, the
chosen outcome measure needs to display a high level of
consistency when measuring the outcome (reliability)
and needs to measure what it is intended to measure
(validity). If these two components are not present, the
ability to reasonably interpret the data presented in the
trial and to generalize the results outside of the trial is
compromised.
Increasingly, specific clinical areas of health care are devel-
oping standarised core sets of outcome measures for use
in research. One example of this is OMERACT (Outcome
Measures in Rheumatoid Arthritis Clinical Trials) [5].
OMERACT has been described as an informal gathering of
professionals interested in outcome measurement in
rheumatology and aims to improve outcome measure-
ment by gaining consensus over which measures are
applicable in trials for each clinical indication[6,7]. This
process not only aids clinical research by standardising
methodology, but also drives further research in areas
where the lack of available research means evidence-based
decisions cannot be made, and assists in the synthesis of
results in systematic reviews and meta-analyses.
In order to make recommendations about choice of out-
come measures for evaluating the effect of implementa-
tion strategies, the measures currently used need to be
described. Importantly, the level at which the effect of the
intervention is being measured (patient versus health
practitioner versus organisational/system) needs to be
determined. The reliability and validity of these measures
and methods also need to be established.
To date, no published studies have attempted to assess
which outcome measures have been used to determine
the effectiveness of strategies aimed at improving develop-
ment, dissemination, and implementation of clinical
practice guidelines.
The primary objective of this study was to identify meth-
ods that have been used to evaluate the outcome of strat-
egies for the dissemination and implementation of
guidelines.
The secondary objectives were to describe the way in
which the outcome measures were applied, the time taken
to collect the data for each of these measures, and, where
reported in the studies, the reliability and/or validity of
the methods used.
Methods
The recent systematic review by Grimshaw et al. was used
as the source of included studies for this review [2]. This
review performed a comprehensive search of the literature
(1966–1998) and identified 235 studies (randomised
controlled trials, controlled clinical trials, controlled
before and after studies and interrupted time series stud-
ies) that assessed the effectiveness of various guideline dis-
semination and implementation strategies.
We obtained copies of all included studies for our data
extraction. Due to difficulties in obtaining the papers,
studies not published in peer-review journals were
excluded. To be included in the data extraction, the out-
come measure(s) needed to be detailed in the methods
and/or results sections of the included study.
One reviewer (SH) used a standardised data collection
form to extract data from the included studies. Extracted
data comprised information about the measure(s) used toImplementation Science 2006, 1:29 http://www.implementationscience.com/content/1/1/29
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assess the effectiveness of the intervention, method(s)
used to collect data for the outcome measure(s), and the
reliability and/or validity of the chosen outcome measure
(where reported in the included study).
Outcome measures used were grouped into five distinct
categories based on the following criteria:
A. Patient level
1. Measurements of actual change in health status of the
patient, i.e., pain, depression, mortality, and quality of
life. (A1)
2. Surrogate measures of A1, i.e., patient compliance,
length of stay, and patient attitudes. (A2)
B. Health practitioner level
1. Measurements of actual change in health practice, i.e.,
compliance with guidelines, changes in prescribing rates.
(B1)
2. Surrogate measures of B1, such as health practitioner
knowledge and attitudes. (B2)
C. Organisational or Process level
Measurements of change in the health system (i.e., wait-
ing lists), change in policy, costs, and usability and/or
extent of the intervention. (C)
In instances where the outcome measure was aimed at
measuring change in more than one category, it was
recorded in both of the categories (e.g. a measure of
number of mammograms where the intervention was tar-
geted at changing patient and health practitioner behav-
iour was classified as A2 and B1). When the intervention
was only targeting health practitioner behaviour, the
intervention was classified only as B1.
Data were then extracted for each study, as to the number
of different categories the outcome measures represented.
Rather than extracting the actual number of outcome
measures used, this approach was the most appropriate
way to represent the results, as the objective of this study
was to determine the types of outcome measures being
used to assess practice change rather than the frequency of
their use within studies.
For each included study, the various methods for collect-
ing the data for the outcome measures were extracted.
Each method of data collection was counted only once,
even if the same method was used more than once for dif-
ferent outcomes in the same included study; for example,
patient survey to determine health practitioner compli-
ance and patient satisfaction questionnaire. Conversely, a
study may have used more than one method to collect
data for the same outcome measure (e.g. both a compu-
terised and manual medical record audit). In this
instance, both outcome measure methods were counted.
One of the authors, (SH) following a pilot of the data
extraction (n = 20), identified the methods used to collect
the data for the outcome measures and grouped them into
nine categories:
1. Medical record audit
￿ Data collected through audit of the patients' chart/med-
ical history;
2. Computerised medical record audit
￿ Data collected through an audit of a computerised ver-
sion of the patients' chart/medical history;
3. Health practitioner survey/questionnaire/interview
￿ Data collected from the health care provider through
surveys or questionnaires either written or verbal, and
interviews either in person or by telephone;
4. Patient survey/questionnaire/interview
￿ Data collected from patients, families, and/or the gen-
eral community through survey and questionnaires either
written or verbal, and interviews either in person or by tel-
ephone;
5. Computerised database
￿ Data collected from centralised computer databases
such as pharmacy prescription registers, medical billing
information;
6. Log books/department record/register
￿ Data collected from organisational documents such as a
register of presentations to the emergency department, log
book of x-ray requests;
7. Encounter chart/request slips/diary
￿ Data collected from forms completed by the health prac-
titioner, encounter forms designed for the study contain-
ing details required for the data collection, request slips
(i.e., laboratory tests), and/or diary kept for the study data
collection;Implementation Science 2006, 1:29 http://www.implementationscience.com/content/1/1/29
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8. Other
￿ Data collected from outcome measures not included in
any of the above categories, such as clinical examination,
results of blood tests, video/audio taping of consultations;
and
9. Unclear
￿ The exact method of data collection could not be estab-
lished.
Following data extraction, data were entered into a data-
base and descriptive statistics used to describe the propor-
tions of studies using various levels of outcome.
Results
Of the 235 studies included in the systematic review by
Grimshaw et al., 228 were included in this review [2].
Seven were excluded as they were not published in a peer-
reviewed journal (see Table 1). Full details of all extracted
data can be obtained from the first author on request.
The average number of outcome measurement categories
used in the included studies was 2.1 (SD = 1.0). Table 2
details the number of outcome measurement categories
used in the studies and the actual categories used. Overall,
the majority (65%) of studies included measures that cov-
ered one or two of the outcome measure categories.
Nearly all (93%) of the studies measured outcomes at the
level of the practitioner, and 13% used a surrogate meas-
ure of practitioner change. Twenty-nine percent of studies
used an actual measure of patient change, and 39% used
a surrogate measure of patient change. Change was meas-
ured at an organisational and/or process level in 38% of
studies. (Figure 1)
Twelve studies had unclear methods of data collection
and were excluded from the analysis of data collection
methods. Approximately one-half (51%, 110/216) of the
included studies used a medical record audit to collect
data for their chosen outcome. A computerised database
was used in 31% of studies, while practitioner interviews,
questionnaires and/or surveys were used in 30% of stud-
ies. Less frequent was the use of patient interviews, ques-
tionnaires, and/or surveys (25%), an encounter chart,
request slip or diary (16%), a computerised medical
record (13%), and a logbook, department record or regis-
ter (11%). Other methods were used in 14% of studies.
(Figure 2)
Forty-six (20%) of the 228 studies indicated that they had
assessed the reliability and/or validity of one or more of
their methods used to collect data for their outcome meas-
ure(s). Reliability of the medical record audit was assessed
in 29 studies. This accounts for 63% of the total number
of studies assessing reliability and/or validity, and 26% of
the total number of studies that used this method of data
collection. Inter- and/or intra-rater reliability of medical
record audit was assessed most commonly through a re-
audit of a selection of the records.
Thirty-two studies used and referenced at least one previ-
ously developed scale and/or questionnaire. In 25 of these
studies (78%), the outcome was measured with a patient
interview, survey or questionnaire, accounting for almost
half (46%) of the studies that measured outcomes with
this method. In total, 29 of the studies (91%) that used a
previously developed scale and/or questionnaire did so to
measure change at the patient level.
A1: Measures of patient/symptom change
The outcomes in this group measured changes in the
patient's health status, either positive (e.g. reduced blood
pressure, control of asthma) or negative (e.g. worsening of
symptoms, increase in psychosocial problems).
Twenty-six studies used mortality as an outcome measure,
while only three studies specifically assessed quality of
life. Scales used to assess quality of life included both dis-
ease specific and global measures.
The methods used to collect data in this category are sum-
marised in Table 3. The most commonly used method was
a patient interview, survey or questionnaire, and disease
specific questionnaires were used in ten studies. Other
studies using either a patient or practitioner interview/sur-
vey/questionnaire tended to use instruments that had
been designed specifically for the trial.
Measurements of actual patient/symptom change
accounted for 30% of those in the "other" category of data
collection. This reflects the use of clinical tests such as the
assessment of smoking cessation through carbon monox-
ide assessment and/or clinical examination.
A2: Surrogate measures of patient change
Surrogate measures of patient change were further divided
into seven main categories. The methods used to collect
data in this category are summarised in Table 3.
Sixteen of the 90 studies assessed patient satisfaction,
however, only one of these used a scale that had been doc-
umented previously. Where details were provided, the
majority of the other studies used questionnaires in which
the patients were required to rate on an ordinal scale their
satisfaction with various items related to the care they
received.Implementation Science 2006, 1:29 http://www.implementationscience.com/content/1/1/29
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Length of hospital stay was measured in 24 studies, while
the number of health care visits and/or hospitalisations
was measured in 30 studies, and test (e.g. laboratory) use
was measured in eight studies. This information was
obtained most frequently through hospital/computerised
databases, medical record audit, and/or patient interview.
Ten studies measured patient knowledge and/or attitudes.
In six studies, this was assessed through an interview with
the patient, and, in the remaining four studies, a question-
naire was used. One trial used a previously developed
questionnaire, and three studies used adaptations of pre-
viously reported/developed questionnaires. Only three
studies reported the results of validity and/or reliability
assessments of their tool.
Functional status and/or return to work were assessed in
ten studies. A patient interview/questionnaire was used to
measure change in this outcome in all of the studies, and
all but one of these studies used a previously developed
scale/questionnaire.
Patient compliance with treatment/recommendations
was assessed in 38 studies, and in 24 of these studies, the
intervention was targeted at both the patient and the phy-
sician. Therefore, the outcome measure was an assessment
of both a surrogate measure of patient change and an
actual measure of practitioner behaviour change. In the
remaining 14 studies, the measure was purely a reflection
of the patient's compliance, i.e., a questionnaire/interview
to establish compliance with medical recommendations
or compliance with the administration of medications.
B1: Measures of practitioner change
This category objectively measured a change in the behav-
iour of the practitioner targeted by the intervention. The
primary aim of the measure was not to assess change at
the patient level due to a change in the behaviour of the
practitioner, rather, the measures used in this category
reflected practitioner compliance (or non-compliance)
with the implemented guideline.
Measures of practitioner change were the most commonly
used outcomes, with 213 of the 228 studies using at least
one practitioner change measure. Practitioner change was
the outcome measure used in 97% of the studies that
measured outcomes in just one category.
Practice change was measured most frequently by medical
record audit, computerised databases, encounter forms,
request slips or diaries (Table 3). Of the 11 studies using a
practitioner interview or questionnaire, two studies refer-
Table 1: Excluded studies
Reference Author Reason for exclusion
A 4 Anonymous Report not published in peer r/v journal
A85 Grimshaw Report not published in peer r/v journal
A86 Grimshaw Dissertation
A144 Morrison Report not published in peer r/v journal
A154 Onion Dissertation
A208 Thomas Report not published in peer r/v journal
A221 Watson Dissertation
Table 2: Categories of outcome measures used
Number of categories Categories used
 Number of studies
Total
1A 1 B 1 75
27 3
2 A1, A2 A1, B1 A1, C A2, B1 A2, C B1, B2 B1, C 74
56 1 1 8 2 1 0 3 2
3 A1, A2, B1 A1, A2, C A1, B1, C A2, B1, B2 A2, B1, C B1, B2, C 55
19 5 9 6 11 5
4 A1, A2, B1, B2 A1, A2, B1, C A1, B1, B2, C A2, B1, B2, C 21
21 3 1 5
5 A1, A2, B1, B2, C 3
3
A1: Measures of patient change; A2: Surrogate measures of patient change; B1: Measures of practitioner change; B2: Surrogate measures of 
practitioner change; C: Organisational or process level changeImplementation Science 2006, 1:29 http://www.implementationscience.com/content/1/1/29
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Outcome measure data collection methods Figure 2
Outcome measure data collection methods.
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enced assessments of the reliability of their question-
naires, and one study also used an evaluator posing as a
patient to check the accuracy of the practitioners' self-
reported behaviour. In six of the 11 studies, practitioner
interview or questionnaire was the sole means of assessing
change at this level.
Twenty-one studies used patient reporting (primarily
through an interview) to assess practitioners' compliance.
One study assessed the reliability of the patient interview
by checking concordance with physician reporting for a
random selection of physicians and patients, and one trial
used a previously reported scale.
In one study, video-recorded consultations were used to
assess practitioner compliance, and two studies audio-
taped consultations, one of which reported assessing the
reliability of the coding of the taped consultations.
B2: Surrogate measures of practitioner change
Surrogate measures of practitioner change generally
involved the measurement of knowledge and/or attitudes.
All outcomes in this category were assessed through a
practitioner questionnaire or interview, with the majority
using an interview.
Eight studies assessed knowledge alone and seven studies
assessed attitudes alone, while 15 studies assessed both
knowledge and attitudes. Assessment of attitude in this
category encompassed measures that assessed the atti-
tudes of the medical practitioner toward the information
being implemented (i.e., attitudes toward preventive
medicine), and not toward the method of implementa-
tion. Where the trial provided information regarding the
assessment of knowledge, the methods used included case
scenarios, short answer questions, and multiple-choice
questions. Attitudes were most commonly assessed with
the use of a Likert scale[8].
Four studies reported using a previously reported ques-
tionnaire (or modification of), and seven studies assessed
the reliability, feasibility and/or validity of their question-
naire.
C: Organisational or process level change
The majority of studies assessing outcomes in this cate-
gory measured cost and/or items relating to the interven-
tion itself.
Cost was the most commonly used outcome measure in
this category with 49 (56%) of the 87 studies using this as
a measure of organisational change. The use of cost in
these studies has been extensively described in the review
by Grimshaw et al [2]. The number of studies reported in
this review that included cost as an outcome is less than
the 63 as reported by Grimshaw et al. [2]. This is most
likely due to the inclusion criteria for this review (to be
included, the outcome measure needed to be described in
the methods and/or results sections of the paper) and to
the small number of studies excluded from this review.
No methods were recorded for the collection of costs for
35 studies. In the eight studies that specifically collected
data related to cost, a computerised database was used
most frequently to obtain the information.
The implementation strategy was assessed in 43 studies.
The most common methods for measuring the imple-
mentation strategy were through compliance of the prac-
titioners in either implementing the changes or
Table 3: Methods used to collect outcomes for the different outcome measure categories
Measure Category
Method Measures of Patient 
Change
Surrogate Measures of 
Patient Change
Measures of 
Practitioner Change
Surrogate Measures of 
Practitioner Change
Organisational or 
Process Level Change
Medical record audit 32% 29% 45% 0 5%
Computerised medical 
record audit
14% 9% 12% 0 1%
Medical practitioner 
interview/survey/
questionnaire
12% 2% 5% 100% 53%
Patient interview/survey/
questionnaire
37% 4% 10% 0 5%
Computerised database 18% 26% 25% 0 18%
Log book/Department 
record/Register
2% 7% 9% 0 6%
Encounter form/Request 
slip/Diary
8% 3% 13% 0 13%
Other 14% 7% 7% 0 8%
Unclear 9% 14% 7% 0 6%
All numbers are percent of the total number of studies for that category
* Excludes 25 studies that measured cost in this category for which no method was recordedImplementation Science 2006, 1:29 http://www.implementationscience.com/content/1/1/29
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completing the forms, the exposure of the patients and/or
practitioners to the interventions and the heath practi-
tioners' acceptance of the strategies, including their per-
ceived usefulness of the strategy. The most common
method used to collect this information was a survey or
interview of the practitioner (29 studies). An encounter
form, chart or diary was the next most common method,
with seven studies using this method.
Other measures used in this category included changes in
policies and procedures, as well as changes at an organisa-
tional level, such as the presence of the required equip-
ment and the impact of the intervention on the time spent
by the medical practitioner for each consultation.
Discussion
While few of the guidelines implemented in the reviewed
studies were overtly evidence-based, a large proportion of
studies (93%) aimed at improving dissemination and
implementation of clinical guidelines by measuring
change at the health practitioner level. Less than one-third
of studies directly assessed outcomes related to a change
in the health of the patient.
When selecting outcome measures for use in studies of
interventions to implement evidence and change clinical
practice, researchers face the decision of whether to limit
assessment to measures of practice (Did the intervention
change practice?), or the ultimate endpoint of actual
change in patient status or health outcome (Did the inter-
vention improve health status?). When the implementa-
tion intervention targets a clinical behaviour for which
there is strong evidence of benefit, it may be appropriate
to measure outcome only in terms of whether the behav-
iour occurred, making practitioner behaviour an indicator
of the outcome measure or endpoint. In such cases, meas-
urements at the level of the patient, with the associated
additional investment and responder burden, may be a
waste of resources. However, to fail to do so precludes the
study from addressing the overarching question of
whether the implementation of evidence results in
improved patient outcomes. By documenting the out-
come measures used in similar studies to date, we hope to
inform discussion and thought regarding the level at
which outcome should be assessed in future work.
Regardless of whether measures of practitioner behaviour
are viewed as an interim process variable to explain the
impact of the intervention on the ultimate endpoint of
patient outcomes, or as the primary endpoint of the trial,
studies need a valid method of assessing practice change.
Many of the studies did not report the reliability or valid-
ity of the methods used to collect data for their outcome
measure(s), regardless of the level at which they were
assessing change. This invites the possibility that measure-
ment error may bias the results of the investigation of the
strategy. The results presented in this review may underes-
timate the actual number of studies that performed relia-
bility and/or validity testing of their methods, as we were
reliant on this being reported in the paper. However, it is
likely that the proportion of studies in which reliability of
outcome measure and method were determined but not
reported is small, and therefore of minimal impact on our
results.
It is likely that use of surrogate measures of practitioner
change (level B2) is much more prevalent than our study
concludes. Primary studies using only this level of meas-
urement were excluded from the review by Grimshaw et
al. and, as a result, would not have been captured in our
sample, which included this level only if it was used in
combination with outcome assessment at another level.
The use of a medical record audit was the most common
data collection method. The validity of this method of
data collection has been found to be variable depending
on the type of information being extracted [9,10]. Approx-
imately one-quarter of the studies using medical record
audit attempted to assess the reliability and/or validity of
the extraction methods used. In most instances, the test-
ing was limited to assessment of inter-rater reliability.
When medical record audits are used, attention needs to
be paid to the reliability of the record itself, as well as to
the validity of the record and the data extracted from it
[11].
Patient and health practitioner questionnaires, surveys,
and interviews were also widely used. Measurements of
change in practitioner behaviour, knowledge, and/or atti-
tudes (the primary outcome for many studies) through
questionnaires, surveys or interviews demonstrated little
use of previously developed instruments and poor report-
ing of reliability and/or validity of the measures used.
Those studies assessing patient-related outcomes often
used disease-specific or global questionnaires that had
been described previously in the literature. The use of
patient questionnaires has been shown to have similar
variability in validity as that described for medical record
audits [10].
Outcome measures used in other areas of healthcare
research have been described in similar reviews to our
study, i.e., measures used in stroke and shoulder pain tri-
als [12,13]. Others have proposed the use of standard sets
of outcome measures in specific areas, such as those rec-
ommended for low back pain research [14]. Standardising
the use of outcome measures facilitates comparisons
between similar studies and pooling of data for meta-
analysis. However, unlike studies delivered in definedPublish with BioMed Central    and   every 
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clinical areas, studies of implementation strategies will
need to vary to match the clinical setting, and so a core set
of outcome measures may not be possible. However, a
common consensus methodology for outcome assess-
ment in studies of implementation may result in
improved quality. Such a methodology should include
always measuring outcome at least at the level of actual
health practitioner behaviour (B1), including measures of
patient change where there is not strong evidence to sup-
port that the change in behaviour leads to improved
patient outcomes, as well as reporting the reliability and
validity of data collection methods employed in the study.
Conclusion
This paper has described the outcome measures used in
228 studies of effectiveness of dissemination and imple-
mentation interventions for clinical guidelines. Most trials
reported change at the health practitioner level, with less
than one-third of trials measuring whether any change in
practice resulted in a change in the ultimate endpoint of
the patient's health status. Costs were the most reported
measure of change at an organisational level. Medical
record audit, computerised databases, and health practi-
tioner questionnaire/interview were common ways of col-
lecting data. Very few studies demonstrated the reliability
and validity of the methods used. The development of a
common methodology for outcome assessment in studies
of implementation would facilitate comparisons between
studies and the pooling of results.
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